# A Clinical Trial to Evaluate the Efficacy and Safety of Methoxyethyl Etomidate Hydrochloride for Sedation/Anesthesia During Gastroscopy/Colonoscopy

> **NCT06858852** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Ahon Pharmaceutical Co., Ltd.** · enrollment: 270 (estimated)

## Conditions studied

- Gastroscopy
- Colonoscopy

## Interventions

- **DRUG:** ET-26HCl 0.8mg/kg group
- **DRUG:** Etomidate Injectable Product 0.3mg/kg group

## Key facts

- **NCT ID:** NCT06858852
- **Lead sponsor:** Ahon Pharmaceutical Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2025-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06858852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06858852, "A Clinical Trial to Evaluate the Efficacy and Safety of Methoxyethyl Etomidate Hydrochloride for Sedation/Anesthesia During Gastroscopy/Colonoscopy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06858852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*